Stephen Worland

Stephen Worland

Gründer bei
eFFECTOR Therapeutics Operations, Inc.
68 Jahre
Health Technology
Consumer Services
Technology Services

Profil

Stephen T.
Worland
is the founder of eFFECTOR Therapeutics Operations, Inc., founded in 2012, where the title held is President, Chief Executive Officer & Director.
Current jobs include Chief Executive Officer & Director at Numerion Labs, Inc. since 2025, and Director at Blacksmith Medicines, Inc. since 2017.
Former jobs include President, Chief Executive Officer & Director at Anadys Pharmaceuticals, Inc. from 2007 to 2011; President, Chief Executive Officer & Director at eFFECTOR Therapeutics, Inc. from 2021 to 2024; VP-Antiviral Research & Director-Molecular Biology at Agouron Pharmaceuticals LLC from 1988 to 2001; Independent Non-Executive Director at GenMark Diagnostics, Inc. from 2013 to 2015; Director at Forge Therapeutics, Inc.; Independent Director at TRACON Pharmaceuticals, Inc. from 2015 to 2024; Vice President & Head-Antiviral Research at Pfizer Inc. from 2000 to 2001; and Vice President at Warner-Lambert Co. Education includes a doctorate from the University of California, Berkeley, and an undergraduate degree from the University of Michigan.

Aktive Positionen von Stephen Worland

UnternehmenPositionBeginn
Gründer 01.05.2012
Direktor/Vorstandsmitglied 01.04.2017
Vorstandsvorsitzender 18.02.2025

Ehemalige bekannte Positionen von Stephen Worland

UnternehmenPositionEnde
TRACON PHARMACEUTICALS, INC. Direktor/Vorstandsmitglied 31.07.2024
EFFECTOR THERAPEUTICS, INC. Vorstandsvorsitzender 21.06.2024
GENMARK DIAGNOSTICS, INC. Direktor/Vorstandsmitglied 01.02.2015
Vorstandsvorsitzender 23.11.2011
Corporate Officer/Principal 01.01.2001
Sehen Sie sich die Erfahrung von Stephen Worland im Detail an

Ausbildung von Stephen Worland

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

56

Beziehungen ersten Grades

13

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Stephen Worland